Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2036 of 5804
-
Antibiotic vancomycin tested as PSC treatment – trial stopped early
Disease control TerminatedTo find out if vancomycin is a safe and effective therapy for primary sclerosing cholangitis. Funding Source - FDA OOPD
Phase: PHASE2, PHASE3 • Sponsor: Elizabeth Carey • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
App that learns your habits could help tame diabetes
Disease control CompletedIn this project, the investigators will evaluate the efficacy of a novel approach to personalizing behavioral interventions for self-management of type 2 diabetes (T2DM) to individuals' behavioral and glycemic profiles discovered using computational learning and self-monitoring d…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Brain scans reveal how a calming drug affects emotion in psychosis
Knowledge-focused CompletedThe purpose of this study is to better understand mental illness and will test the hypotheses that, while viewing affective stimuli, patient groups will show increased blood oxygenation level dependent (BOLD) signal by fMRI after lorazepam. This study will enroll participants be…
Phase: PHASE4 • Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Smartwatch could screen for sleep apnea, study says
Diagnosis OngoingSleep Apnea Syndrome (SAS) is a common pathology affecting between 4 and 8% of the general population. It aggravates morbidity and cardio-metabolic mortality and is responsible for accidents related to vigilance disorders. It is estimated that 80%% of SAS cases are not diagnosed …
Sponsor: Withings • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Experimental gene therapy targets rare form of duchenne muscular dystrophy
Disease control CompletedOpen-label, single dose clinical trial of scAAV9.U7.ACCA via peripheral limb vein injection for Duchenne muscular dystrophy boys who have a duplication of exon 2.
Phase: PHASE1, PHASE2 • Sponsor: Megan Waldrop • Aim: Disease control
Last updated Jun 26, 2026 16:38 UTC
-
Bladder cancer drug combo trial halted early – what does it mean?
Disease control TerminatedA study comparing nivolumab and bacterial drugs given to help the body's immune system in the bladder versus bacterial drugs alone in high risk bladder cancer participants.
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 26, 2026 18:24 UTC
-
New imaging tech aims to sharpen liver cancer radiation
Disease control OngoingPrimary and secondary liver cancer patients will receive liver SABR with or without KIM intervention.
Phase: NA • Sponsor: University of Sydney • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New directional brain stimulation aims to stop Parkinson's freezing
Disease control CompletedDeep brain stimulation of the NST is effective for cardinal motor signs in patients with idiopathic Parkinson's disease (IPD), its effects on gait disturbances, especially freezing of gait-FOG, and falls are variable from one patient to another, in part depending on the location …
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Could an immunotherapy drug replace hormone therapy for some prostate cancers?
Disease control CompletedMMR-deficient cancers of any histologic type appear to be very sensitive to PD-1 blockade with pembrolizumab, and similar data are also beginning to emerge for nivolumab and other immune checkpoint inhibitors. Among the MMR-deficient cancers, the best antitumor responses are ofte…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Heart study tests stronger blood thinner combo to prevent attacks
Disease control Recruiting nowThis study is a prospective, open label, two-arm, randomized multicenter trial to evaluate the efficacy and safety of aspirin plus prasugrel as compared with aspirin plus clopidogrel in patients undergoing elective percutaneous coronary intervention with drug eluting stents for c…
Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug combo aims to reboot immune attack on head and neck cancer
Disease control OngoingThis phase II single arm study is being done to determine if bavituximab could potentially synergize with PD-1 inhibitor therapy to generate an effective anti-tumor immune response in patients with recurrent/metastatic squamous cell head and neck cancer (HNSCC) who progressed on …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New radiation approach aims to tame pancreatic cancer with fewer side effects
Disease control OngoingStandard chemoradiation, followed by surgery are standard treatment plan for patients suffering from pancreatic adenocarcinoma. Due to damage to the surrounding healthy tissue caused by standard radiation, this study uses a new type of radiation plan- pulsed low-dose rate (PLDR) …
Phase: NA • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Heart surgery patients may need fewer transfusions with EPO and iron combo
Disease control CompletedPreoperative anemia, bleeding and transfusions have been recognized as a "Deadly triad" in cardiac surgery associated with an increased morbidity,mortality, and costs related. Thus strategies to reduce unnecessary RBC transfusions and to optimize preoperative anemia must be devel…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a Bone-Building drug save your new knee?
Disease control CompletedThe investigator hypothesizes that treating osteoporotic patients with abaloparatide prior to and after total knee arthroplasty will significantly reduce the amount of bone loss.
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Teen body image program shows promise in large school trial
Prevention CompletedThis is a cluster randomized controlled trial with two assessment points (baseline and 24-week follow-up) comparing the Claudia Carraro prevention program to a no-intervention control group. The intervention group was also assessed at post-intervention. To ensure that all student…
Phase: NA • Sponsor: Villa Garda Hospital • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Special lenses may curb worsening eyesight in children
Disease control CompletedOrthokeratology (OK) has been demonstrated to be an effective intervention for slowing axial elongation in children with myopia. The proposed mechanism of action is the induction of peripheral myopic defocus, which reduces relative peripheral hyperopia on the retina. This study …
Sponsor: Tianjin Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Spleenless patients under the microscope: can we predict their biggest health threats?
Knowledge-focused Recruiting nowSpleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, an…
Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Electric brain stimulation tested as treatment for gaming addiction
Disease control Recruiting nowThe Internet has grown considerably in the last twenty years, and as a result, cases of excessive iinterney use have emerged. These cases, which have clinical similarities with substance addiction, involve the various activities related to the Internet (online gambling, discussio…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Cash for quitting: does paying smokers to stop work?
Disease control OngoingFinancial incentives for motivating changes in health behavior, particularly for smoking and other morbid habits, are increasingly being tested by health insurers, employers, and government agencies. However, in using incentive programs for smoking cessation, key unanswered struc…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Belly tissue used to bypass brain barrier in cancer fight
Disease control TerminatedThis single center, single arm, open-label, phase I study will assess the safety of a laparoscopically harvested omental free flap into the resection cavity of recurrent glioblastoma multiforme (GBM) patients. All participants included in the study will undergo standard surgical…
Phase: PHASE1 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC